Sfoglia per AUTORE
MUSTO P
Collezione ASL Vercelli

  

Items : 11

Comparison of isatuximab-pomalidomide-dexamethasone versus elotuzumab-pomalidomidedexamethasone in relapsed/refractory multiple myeloma patients: a target trial emulation using real-world data. in Haematologica / Haematologica. 2025 Mar 6. doi: 10.3324/haematol.2025.287325.

2025
ASL Vercelli
AOU Città della Salute di Torino
AOU Novara

Gentile M; Tripepi G; Morabito F; Neri A; Musto P; Petrucci MT; Bolli N; Di Raimondo F; De Stefano V; Morè S; De Paoli L; Barilà G; Benvenuti P; Cotzia E; Mele A; Annibali O; Bertuglia G; Furlan A; Lombardo A; Maggi A; Antonioli E; Aquino S; Tarantini G; Vincelli ID; Farina F; Micozzi J; Roccotelli D; Quaresima M; Barbieri E; et alii...

Isatuximab, pomalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: the Italian, multicenter, retrospective clinical experience with 270 cases outside of controlled clinical trials. in Haematologica / Haematologica. 2025 Apr 1;110(4):1028-1033. doi: 10.3324/haematol.2024.286658. Epub 2024 Nov 28.

2025
ASL Vercelli
AOU Città della Salute di Torino
AOU Novara

Morabito F; Musto P; Di Raimondo F; Petrucci MT; Neri A; Coscia M; Galli M; De Stefano V; Amico V; Di Renzo N; Quinto AM; Brunori M; Cotzia E; Pietrantuono G; Montefusco V; Gozzetti A; Neri S; Monachesi M; Maggi A; Zambello R; Lombardo A; Citro A; Uccello G; Roccotelli D; Amendola A; Califano C; Morè S; Rivolti E; Nappi D; et alii...

SUPPORTING TREATMENT DECISION-MAKING FOR LENALIDOMIDE- REFRACTORY MULTIPLE MYELOMA PATIENTS POSTDRD IN ITALY: A MULTI-CRITERIA DECISION FRAMEWORK in Haematologica

2025
ASL Vercelli

Boccadoro M; Belotti A; Bombaci F; Bringhen S; Buda G; Cafro AM; Caimmi M; Canali B; Canonico PL; Cavo M; Corso A; De Paoli L; Derudas D; Di Raimondo F; Galeone C; Gay F; Gentile M; Giuliani N; La Malfa P; Mercati R; Montefusco V; Musto P; Offidani M; Patriarca F; Petrucci MT; Riccaboni M; Tosi P; Zamagni E; Zambello R; et alii...

Continous or fixedcarfilzomib, lenalidomide and dexamethasone (krd) for relapsed-refractory multiple myeloma: long-term follow-up from a multicenter, retrospective real-life surveyfrom European myeloma network (emn) Italy in Annals of Hematology

2025
ASL Vercelli

Conticello C; Fabro VD; Romano A; Mele A; Mina R; Bringhen S; Orofino A; Antonioli E; Pulini S; De Paoli L; Za T; Cotzia E; Elia F; Casson A; Prete E; Citiso S; Liberatore C; Margiotta-Casaluci G; Fazio F; Morè S; Attucci I; Accardi F; Bongarzoni V; Mangiacavalli S; Rossi E; Mannina D; Garibaldi B; Rizzi R; Di Cecca M; et alii...

Isatuximab, Pomalidomide, and Dexamethasone (IsaPd) As Salvage Therapy for Patients with Multiple Myeloma: Multicenter, Retrospective Clinical Experience with 262 Cases Outside of Controlled Clinical Trials in Blood

2024
ASL Vercelli

Martino EA; Derudas D; Rossi E; Terlizzi S; Reddiconto G; Stefanoni P; Micozzi J; Mangiacavalli S; Zamagni E; Offidani M; Furlan A; Buda G; Lotti F; Liberatore C; Lazzaro A; Della Pepa R; Bertuglia G; Barbieri E; Conticello C; De Magistris C; De Paoli L; Bongarzoni V; Cafro AM; Mele A; Benvenuti P; Cerchione C; Botta C; Antonioli E; Sgherza N; et alii...

Features, reason for testing, and changes with time of 583 paroxysmal nocturnal hemoglobinuria clones from 529 patients: a multicenter Italian study. in Annals of hematology / Ann Hematol. 2019 May;98(5):1083-1093. doi: 10.1007/s00277-019-03644-8. Epub 2019 Mar 13.

2019
AO Ordine Mauriziano
AOU Città della Salute di Torino
ASL Vercelli

Statuto T; Ferrari L; Oliva B; Mestice A; Amodeo R; Arras M; Boscaro E; Bartocci C; Santonocito AM; Ottaviano V; Del Pup L; Pavanelli MC; Ulbar F; Poletti G; Lo Pardo C; De Rosa C; Pantano G; Catinella V; Caporale R; Ciriello MM; Omedè P; Tedone E; Vanelli L; Conte CA; Cesaro S; Michelutti A; Regazzoli A; Lanza F; Buccisano F; et alii...

Safety and efficacy of rituximab plus bendamustine in relapsed or refractory diffuse large B-cell lymphoma patients: an Italian retrospective multicenter study. in Leukemia & lymphoma / Leuk Lymphoma. 2016 Aug;57(8):1823-30. doi: 10.3109/10428194.2015.1106536. Epub 2015 Dec 15.

2016
ASL Vercelli
AOU Città della Salute di Torino

Cox MC; Gentile M; Marino D; Ghio F; Savini P; Carli G; Musto P; Ilariucci F; Zambello R; Santagostino A; Cabras MG; Tani M; Marasca R; Valenti V; Bernuzzi P; Zanlari L; Spina M; Chiappella A; Arcari A; Vallisa D;

Safety and Efficacy of Rituximab Plus Bendamustine in Relapsed or Refractory Diffuse Large B-Cell Lymphoma Patients in Blood

2014
ASL Vercelli

Arcari A; Chiappella A; Valenti V; Zanlari L; Tani M; Marasca R; Cabras MG; Spina M; Santagostino A; Ilariucci F; Carli G; Musto P; Savini P; Marino D; Ghio F; Gentile M; Cox MC; Della Seta R; Vallisa D;

Azacitidine for the treatment of patients with acute myeloid leukemia: Report of 82 patients enrolled in an Italian compassionate program in Cancer

2012
ASL Vercelli

Maurillo L; Venditti A; Spagnoli A; Gaidano G; Ferrero D; Oliva E; Lunghi M; D'Arco AM; Levis A; Pastore D; Di Renzo N; Santagostino A; Pavone V; Buccisano F; Musto P;

Bendamustine (B) in combination with rituximab (R) for patients with relapsed/resistant chronic lymphocytic leukemia (CLL): An Italian multicentre retrospective study in Haematologica

2010
ASL Vercelli

Iannitto E; Morabito F; Mancuso S; Gentile M; Augello A; Bongarzoni V; Cascavilla N; D'Arco A; Di Renzo N; Fazzi R; Ferrara F; Franco G; Gobbi M; Liardo E; Liberati AM; Marasca R; Montanini A; Mulè A; Musso M; Musto P; Pennese E; Piccin A; Rota Scalabrini D; Sciacca M; Visani G; Abbadessa V; Rigacci L;

Azacitidine for the treatment of lower risk myelodysplastic syndromes: A retrospective study of 74 patients enrolled in an Italian named patient program in Cancer

2010
ASL Vercelli

Musto P; Maurillo L; Spagnoli A; Gozzini A; Rivellini F; Lunghi M; Villani O; Aloe-Spiriti MA; Venditti A; Santini V; Leone G; Voso MT; D'Arco AM; Tatarelli C; Ferrero D; Gaidano G; Palumbo G; Di Raimondo F; Oliva E; Sanpaolo G; Tonso A; Santagostino A; Filardi N; Pollio B; Candoni A; Fili C; Russo D; Orciuolo E; Petrini M; et alii...